Remove Immunization Remove Magazine Remove Vaccines
article thumbnail

Bharat Biotech acquires licence for GSK’s Shigella vaccine development

Pharmaceutical Technology

June 13, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook GSK’s vaccine leverages GMMA technology. GSK has licensed altSonflex1-2-3, its Shigella vaccine candidate, to Bharat Biotech for continued development and distribution in low and middle-income nations. Can pharma tariffs “Make America Manufacture Again”?

article thumbnail

QS-21, the ‘Gold Standard’ of immune system activators used in Covid-19 and other vaccines to be presented by CEO Gaston Salinas at BIO CEO & Investor Conference

Pharma Mirror

A novel approach for ensuring the virtually unlimited production of QS-21, the ‘Gold Standard’ adjuvant for improving vaccine efficacy, will be the subject of an upcoming presentation at the BIO CEO & Investor Digital Conference, starting February 16.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Realising the promise of cancer vaccines

pharmaphorum

For years, the promise of therapeutic cancer vaccines has intrigued researchers working in the oncology space. The concept of pre-emptively training the immune system to increase the frequencies of tumour-reactive T cells could be game-changing for cancer patients worldwide. And for good reason.

article thumbnail

NSW government invests $13.39m in life-changing therapies

Pharmaceutical Technology

Find out more This treatment involves obtaining immune cells from patients, modifying them in a laboratory setting then reintroducing them into patients’ bodies to destroy cancerous cells. Can pharma tariffs “Make America Manufacture Again”? Data Insights The gold standard of business intelligence.

article thumbnail

Vaccine sceptics among new members hired by RFK Jr for CDC’s vaccine panel

Pharmaceutical Technology

US Health Secretary Robert F Kennedy (RFK) Jr has appointed eight new members to the vaccine advisory panel at the Centers for Disease Control and Prevention (CDC), just days after firing the panel’s previous members in full. Can pharma tariffs “Make America Manufacture Again”? Credit: LightRocket via Getty Images. Who’s on the panel?

article thumbnail

Gilead hit with FDA clinical hold for batch of HIV trials

Pharmaceutical Technology

CD4+T-cells and lymphocytes are both crucial elements of the immune system. Can pharma tariffs “Make America Manufacture Again”? Low levels of either increase the likelihood of infections and other health problems. HIV itself can reduce CD4 count – a value lower than 200 indicates acquired immunodeficiency syndrome (AIDS).

article thumbnail

EHA 2025: AstraZeneca’s surovatamig is potential next-gen BiTE for R/R B-ALL

Pharmaceutical Technology

A low incidence of immune effector cell-associated neurotoxicity syndrome was reported during the step-up dosing phase and the target dose phase. Can pharma tariffs “Make America Manufacture Again”? Two patients experienced dose-limiting toxicities and continued to receive the targeted dose.